Dpat 60 is a generic antiviral medication manufactured by Natco Pharma. It contains Daclatasvir 60 mg, a direct-acting antiviral (DAA) used in the treatment of chronic Hepatitis C virus (HCV) infection.
Category | Antiviral |
Brand | Natco |
Ingredient | Daclatasvir Dihydrochloride |
Prescription Required | Yes |
Strength | 60mg |
Package | 30 Tablets |
Dpat 60, which contains the active ingredient Daclatasvir 60 mg, works by inhibiting the NS5A protein in the Hepatitis C virus (HCV). This protein is essential for the replication and assembly of the virus. By blocking the NS5A protein, Daclatasvir prevents the virus from multiplying and spreading throughout the body. It helps to control the infection and reduces the viral load, making it an effective treatment for chronic HCV infections.
Dpat 60, which contains Daclatasvir 60 mg, offers significant benefits in the treatment of chronic Hepatitis C virus (HCV) infections. It works by inhibiting the NS5A protein, a crucial component for the replication of the virus. By blocking this protein, Dpat 60 helps reduce the viral load, ultimately controlling the infection and improving liver function.
Common Side Effects:
The most common side effects of Dpat 60 are
• Fatigue
• Headache
• Nausea
• Diarrhea
• Insomnia (difficulty sleeping)
• Loss of appetite
• Anemia (low red blood cell count)
Other side effects of Dpat 60 can include
• Rash or skin reactions
• Muscle pain or weakness
• Elevated liver enzymes (may indicate liver irritation or damage)
• Swelling in the hands, feet, or ankles
• Shortness of breath or difficulty breathing
• Jaundice (yellowing of the skin or eyes)
• Dark urine or light-colored stools
• Confusion or changes in mental status (though rare)
• Severe fatigue or malaise
Dpat 60 (Daclatasvir 60 mg) should not be taken by certain individuals due to potential risks. It is contraindicated in pregnant women, as it may harm the developing fetus, and should not be used by breastfeeding mothers, as it is not known whether the drug passes into breast milk. Additionally, children and adolescents under 18 years of age should avoid using Dpat 60, as its safety and efficacy in this age group have not been established.
Dpat 60 (Daclatasvir 60 mg) should be taken exactly as prescribed by your healthcare provider. Typically, it is taken once a day, with or without food. The medication should be swallowed whole with a glass of water and should not be crushed or chewed.
There are no reviews yet.